ODIN focuses on areas that hold a strong potential for the Danish ecosystem and global health in general. The overall focus is on the early, explorative (i.e. precompetitive) phases of drug discovery and clinical diagnostics. Highly innovative, high-risk projects are encouraged.
Core Scope
Expanded Scope (for broader healthcare applications)
Research within the expanded scope areas of ODIN may extend beyond the core scope, provided it is clearly demonstrated how the technology, tool, or method can eventually be applied to at least one of the core scope areas.
The ODIN application guidelines will tell you all you need to know about the application process, but here are the basics:
Ideas and applications are posted through WorldLabs. All templates can be found in WorldLabs under the call for which you are applying.
A standard Project Agreement is to be entered by all project participants before starting an ODIN project. The agreement is non-negotiable, as the terms have already been defined by the founding companies and partner universities for the purpose of ease-of-collaboration. The Project Agreement can be found here at the website under "About ODIN". Here you can also find the application guidelines, which provide futher information on the important date and events in the 2025 call for applications.
We unite bright minds from industry and academia to jointly create need-driven clinical research projects - and pave the way for innovative new treatments and diagnostics. We fund the best project ideas through competitive funding calls. Although companies cannot receive funding, it is free of charge to join.
The platform is sponsored by the Novo Nordisk Foundation with 180 million DKK from 2024-2029.
You are welcome to contact us if you have questions or comments. Reach out to odin@au.dk or find the Secretariat's direct email addresses under contacts.
Although the platform spans five Danish universities, we're based in Aarhus. Our office is located at Aarhus University, Ny Munkegade 120, blg 1521-214.